Subscribe
COVID-related stressors and increasing instances of substance abuse

The Podcast by KevinMD

COVID-related stressors and increasing instances of substance abuse

"While the rise in substance use disorders during COVID will become more apparent as the pandemic eventually ebbs, the silver lining is that this is not a novel problem. We…
November 15, 2020
ADVERTISEMENT
EHRGo-THE FUTURE OF HEALTHCARE EDUCATION

COVID-related stressors and increasing instances of substance abuse

“While the rise in substance use disorders during COVID will become more apparent as the pandemic eventually ebbs, the silver lining is that this is not a novel problem. We understand substance use disorders far better than we understand COVID-19, and we also know that one of the largest obstacles to treatment is the shame associated with admitting that one has a problem. Furthermore, we also possess lifesaving drugs (such as Naloxone) that can prevent those with opioid use disorder from dying of an overdose.

Moving forward, we in the mental health community should encourage efforts to eliminate stigmas associated with addiction. More concretely, policymakers should be ready for the increase in opioid-related overdoses and ensure first responders have access to drugs like Naloxone. Secondly, COVID-19 patients and family members should receive easier access to mental health care to improve resiliency and potentially reduce instances of substance abuse disorders that begin as PTSD-related self-medication.”

Samoon Ahmad is a psychiatrist.

He shares his story and discusses his KevinMD article, “COVID-related stressors and increasing instances of substance abuse.” (https://www.kevinmd.com/blog/2020/08/covid-related-stressors-and-increasing-instances-of-substance-abuse.html)

ADVERTISEMENT
EHRGo-THE FUTURE OF HEALTHCARE EDUCATION

You may also like

The Best Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Medicines360 is constructing healthcare for women everywhere Dr. Jessica Grossman is the CEO of Medicines360, discusses increasing affordability and accessibility in women's health, equity in clinical studies, and demystifying birth control.